NCT05395429View on ClinicalTrials.gov

Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients

UnknownOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

March 25, 2022

Primary Completion Date

November 15, 2023

Study Completion Date

December 15, 2023

Conditions
Thyroid Cancer
Trial Locations (4)

Unknown

RECRUITING

First Affiliated Hospital, Sun Yat-Sen University, Guangzhou

RECRUITING

First Affiliated Hospital of Kunming Medical University, Kunming

RECRUITING

Tianjin Medical University Cancer Institute and Hospital, Tianjin

RECRUITING

Yunnan Cancer Hospital, Yunnan

Sponsors

Lead Sponsor

Genetron Health
All Listed Sponsors
collaborator

Tianjin Medical University Cancer Institute and Hospital

OTHER

collaborator

First Affiliated Hospital, Sun Yat-Sen University

OTHER

collaborator

Yunnan Cancer Hospital

OTHER

collaborator

First Affiliated Hospital of Kunming Medical University

OTHER

lead

Genetron Health

INDUSTRY

NCT05395429 - Clinical Evaluation of Genetron TERT/BRAF PCR Kit in Thyroid Cancer Patients | Biotech Hunter | Biotech Hunter